Whitehawk Therapeutics

Pacific Palisades, United States

Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.

May 2026

Post-IPO Equity

Biopharma Biotechnology Life Science Oncology

Top Investors

Vivo CapitalOrbiMedRTW InvestmentsDecheng CapitalAlly Bridge Group

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Whitehawk Therapeutics

Who are Whitehawk Therapeutics's investors?

Whitehawk Therapeutics's investors include Vivo Capital, OrbiMed, RTW Investments, Decheng Capital, Ally Bridge Group.

Where is Whitehawk Therapeutics headquartered?

Whitehawk Therapeutics is headquartered in Pacific Palisades, United States.

What does Whitehawk Therapeutics do?

Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.

What stage is Whitehawk Therapeutics at?

Whitehawk Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 13, 2026.

MLA

"Whitehawk Therapeutics — Funding & Investors." VCBacked, May 13, 2026, https://www.vcbacked.co/company/whitehawk-therapeutics. Accessed June 4, 2026.

APA

VCBacked. (2026). Whitehawk Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/whitehawk-therapeutics

Wikipedia (cite web)

{{cite web |title=Whitehawk Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/whitehawk-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 13, 2026.